SilverArc Capital Management key facts
- SilverArc Capital Management is a hedge fund based in Boston, Massachusetts with 4 tracked portfolio companies.
- Notable positions include CORXEL Pharmaceuticals, Manifold, Congruence Therapeutics.
- The team roster lists 2 people.
- SilverArc Capital Management reports $1.1B in regulatory assets under management across 3 private funds, per its SEC Form ADV (2026-03).
About SilverArc Capital Management
Founded in 2012, SilverArc Capital Management is a hedge fund manager based in Boston, Massachusetts. The firm seeks to invest in healthcare, drug companies, biotechnology, specialty pharmaceuticals, drug manufacturers, pharmaceutical, medical device, medical diagnostic, and life sciences companies across the United States. The firm's investment strategies include long/short and sector-oriented investment strategies. The firm's asset exposure includes equities, derivatives, fixed income, and foreign currencies. The firm's style preferences include volatility, small-cap, and mid-cap style preferences.
Investment focus
Its SEC Form ADV lists $1.1 billion in regulatory assets under management across 3 private funds (Mar 2026).
SilverArc Capital Management portfolio at a glance
4 portfolio companies are on record for SilverArc Capital Management, including CORXEL Pharmaceuticals, Manifold and Congruence Therapeutics.
SilverArc Capital Management team
2 people are on record at SilverArc Capital Management. Senior names include Andrew Timpson (Chief Operating Officer) and Devesh Sharad Gandhi (Founder). 2 of them have a verified direct contact on file.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
SilverArc Capital Management at the SEC
Form ADV · 2026-03 · CRD 304220- Regulatory AUM
- $1.1B
- Private fund assets
- $935.3M
- Private funds
- 3 · 1 venture, 2 hedge
- Staff
- 9
- Registered office
- BOSTON, MA
- SEC status
- Approved
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as SILVERARC CAPITAL MANAGEMENT, LLC).
- ·The top 10 names in the book — of 4 recorded positions
- ·Watchlist + alerts for SilverArc Capital Management's activity
Portfolio
4 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| CORXEL Pharmaceuticals | Drug Discovery | ▮ | ▮ | ▮ |
| Manifold | — | ▮ | ▮ | ▮ |
| Congruence Therapeutics | — | ▮ | ▮ | ▮ |
+ 1 more companies · all 4, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked about SilverArc Capital Management
- What companies does SilverArc Capital Management invest in?
- SilverArc Capital Management has 4 recorded portfolio companies, including CORXEL Pharmaceuticals, Manifold, Congruence Therapeutics.
- What is SilverArc Capital Management's AUM?
- SilverArc Capital Management manages approximately $1.0B in assets.